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Population-based studies of relationships
between dietary acidity load, insulin
resistance and incident diabetes in Danes
Joachim Gæde1†, Trine Nielsen1†, Mia L. Madsen1, Ulla Toft2, Torben Jørgensen2,3,4, Kim Overvad5,
Anne Tjønneland5, Torben Hansen1, Kristine H. Allin1,6 and Oluf Pedersen1*
Abstract
Background: It has been suggested that the acidity of the diet may be related to increased risk of type 2 diabetes.
To investigate this hypothesis, we tested if the acidity of the diet, measured as the Potential Renal Acid Load (PRAL)
score, was associated with incident diabetes and diabetes-related intermediary traits.
Methods: A total of 54,651 individuals from the Danish Diet, Cancer and Health (DCH) cohort were included in the
prospective cox regression analyses of incident diabetes over a 15 years follow-up period. Moreover, 5724 Danish
individuals with baseline data from the Inter99 cohort were included in the cross sectional, multivariate and logistic
regression analyses of measures of insulin sensitivity, insulin release and glucose tolerance status derived from an oral
glucose tolerance test (OGTT).
Results: In the DCH cohort a trend analysis showed that quintiles of PRAL score were, after multifactorial adjustment,
associated with a higher incidence of diabetes (ptrend = 6 × 10
− 7). HR for incident diabetes was 1.24 (1.14; 1.35) (p = 7 ×
10− 7) between first and fifth PRAL score quintile.
In Inter99 higher PRAL score associated with insulin resistance as estimated by lower BIGTT-Si (an OGTT-derived index
of insulin sensitivity) (p = 4 × 10− 7) and Matsuda index of insulin sensitivity (p = 2 × 10− 5) as well as higher HOMA-IR
(p = 0.001). No association was observed for measures of insulin release, but higher PRAL score was associated
with lower OGTT-based disposition index.
Conclusions: A high dietary acidity load is associated with a higher risk of diabetes among middle-aged Danes.
Although adjustment for BMI attenuated the effect sizes the association remained significant. The increased risk of
diabetes may be related to our finding that a high dietary acidity load associates with impaired insulin sensitivity.
Keywords: Dietary acid load, PRAL, Glucose, Insulin resistance, Disposition index, Type 2 diabetes
Background
Accumulating evidence suggests that a high dietary acid-
ity load results in chronic tissue metabolic acidosis
which, in turn, may contribute to the development of in-
sulin resistance and type 2 diabetes (T2D) [1–5].
Observational studies report that a high dietary acidity
load associates with the risk of developing T2D: an epi-
demiological study of ~ 66,000 middle-aged French
women, including 1372 incident T2D cases, reported a
higher incidence of T2D during 14 years of follow-up in
those study participants with a high dietary acidity load
[6]. Also, in an analysis combining data from three ob-
servational studies of American health professionals with
a total of 15,305 cases of T2D in 4,025,131 person years
of follow-up, the authors reported an increased risk of
T2D with a higher PRAL score [7]. Yet, this finding
could not be reproduced in a Swedish study of 911 eld-
erly men with 115 cases through 18 years of follow-up
[8]. Gender discrepancies have been suggested since a
study of 1191 incident cases of T2D among ~ 65,000
Japanese showed an association with T2D in men only
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during 5 years of follow-up [9]. Finally, higher dietary
acidity load was reported to associate with increased
insulin resistance in a study of 1732 Japanese (> 90%
men) [10].
A widely used approach to estimate dietary acidity
load is the Potential Renal Acid Load (PRAL) score
which is a validated proxy for renal net acid excretion
[11]. Another estimation for the acidity of the diet is the
NEAP score (Net Endogenous Acid Production). Both
estimates seem to reflect a similar risk of incident dia-
betes [6, 7, 9, 10].
The PRAL score is based on dietary intake of protein
and various micronutrients, phosphorus, potassium, cal-
cium and magnesium, and takes into account the ab-
sorption rate of the nutrients in the gut, unlike the
NEAP score, which only operates with potassium and
protein intake [6]. A negative PRAL score reflects an al-
kalizing potential of the diet whereas a positive PRAL
score reflects an acidifying potential of the diet.
The aim of the present study was to substantiate and
elaborate previous findings and test if PRAL score asso-
ciates with impaired glucose tolerance and incident dia-
betes in our study sample of middle-aged people from
the general Danish population. Furthermore, in a cross
sectional study of middle-aged individuals from the
Danish general population, we aimed to test the hypoth-
esis that a higher PRAL score associates with diabetes-
related intermediary traits, including impaired beta-cell
function and insulin resistance, derived from Oral
Glucose Tolerance Tests (OGTT).
Methods
The present study is based on two Danish population-
based cohorts: the Diet, Cancer and Health cohort
(DCH) and the Inter99 cohort (ClinicalTrials.gov ID
no. NCT00289237).
Diet, Cancer and health cohort
During 1993 to 1997, 160,725 Danish men and women
were invited to participate in the DCH cohort; the inclu-
sion criteria being age 50–64 years, living in the greater
Copenhagen and Aarhus areas, born in Denmark and
not registered with a previous cancer diagnosis in the
Danish Cancer Registry. In total, 27,178 men and 29,875
women participated. However, 574 individuals were ex-
cluded due to cancer diagnosis before baseline, leaving
56,479 participants available for analysis.
The present study is based on data from 25,808 men
and 28,843 women after exclusion of patients with
known diabetes at baseline (n = 1371), participants with
incomplete dietary registration (n = 53), participants
with extreme values of self-reported energy intake (<
1000 KJ/day (n = 0) or > 20,000 KJ/day (n = 197)) and
participants with missing values for BMI and lifestyle
characteristics (diet, smoking and physical activity)
(n = 207). Information on incident diabetes during the
15 years of follow-up was obtained from The National
Diabetes Register [12] and dates of death were obtained
from the Danish Civil Registration System. All other in-
formation was collected at baseline. A flowchart is given
in Additional file 1: FigureS1.
In the DCH cohort, diet was monitored at recruitment
by a 192-item FFQ that each participant received by mail
before their visit to the study centre. The FFQ was de-
signed specifically for this study population, aiming to
capture the average intake of different food and beverage
items over the past 12 months before study inclusion.
Daily intakes of foods and nutrients were calculated for
each participant by the software programme FoodCalc
(www.ibt.ku.dk/jesper/foodcalc/). A description of the
development and validation of this FFQ, and a detailed
description of the estimation of the dietary intake of the
population have been published [13–16]. Information on
smoking habits and physical activity was obtained from
questionnaires.
Inter99 cohort
The Inter99 cohort is a non-pharmacological interven-
tion study for the prevention of ischaemic heart disease
[17]. Detailed description of the Inter99 study is given in
the Additional file 1.
The present study is based on data from 2843 men
and 2881 women after exclusion of participants with
incomplete dietary registration (n = 150), participants
with missing data from the OGTT (n = 359) and
participants with extreme values of self-reported en-
ergy intake (< 1000 KJ/day (n = 6) or > 20,000 KJ/day
(n = 93)). Additionally, 19 individuals had fasting
serum C-peptide levels lower than 150 pmol/l and
were, due to suspicion of type 1 diabetes, excluded
from further analyses. Four hundred thirty-three indi-
viduals had missing information on smoking, physical
activity, dietary intake or body mass index (BMI) and
were thus excluded. A flowchart is given in
Additional file 1: FigureS2.
Based on OGTT derived data, participants were char-
acterised as having normal glucose tolerance (NGT)
(n = 4288), impaired fasting glucose (IFG) (n = 474), im-
paired glucose tolerance (IGT) (n = 655) or screen de-
tected, treatment-naive T2D (n = 214) according to the
1999 WHO criteria [18]. Additionally, a self-reported
diabetes diagnosis was reported for 93 participants. In
the present analytical protocol, individuals with com-
bined IFG and IGT are presented together in the IGT
group.
In the multivariate analyses of diabetes-related inter-
mediary traits, participants with self-reported diabetes at
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baseline were excluded (n = 93) leaving 5631 participants
eligible for analysis.
To assess beta cell function we used insulinogenic
index and corrected insulin response as well as dispos-
ition index. To review insulin sensitivity we used
Homeostatic Model Assessment of Insulin Resistance
(HOMA-IR), Matsuda index of insulin sensitivity (ISIMat-
suda) and BIGTT-Si. Calculations of these indices are
given in Additional file 1.
The Inter99 study participants completed, at recruit-
ment, a validated and self-administered food frequency
questionnaire (FFQ) during their visit to the Research
Centre [19]. They were asked to report their dietary in-
take during the month before examination. The FFQ in-
cluded 198 questions on food items and beverages with
additional questions regarding portion sizes of selected
food items. All food items in the FFQ were linked to a
food item in the Danish Food Composition Databank
[20]. A detailed description of the questionnaire and es-
timation of the dietary intake of the population has been
published [19]. Smoking status and physical activities
were obtained from validated questionnaires as reported
[17].
The potential renal acid load (PRAL) score
PRAL score was derived based on the estimated intake
of several nutrients calculated from the FFQ used in In-
ter99 and DCH [6]:
PRAL
mEq
day
 
¼ 0:49 protein g
day
 
þ 0:037
 phosphorus mg
day
 
−0:021
 potassium mg
day
 
−0:013
 calcium mg
day
 
−0:026
magnesium mg
day
 
Statistical analyses
All statistical tests were performed using the R statistical
package (http://cran.r-project.org/, version 3.1.3). A
p-value of < 0.05 was considered statistically significant.
In the DCH cohort, Cox proportional hazards regres-
sion models with age as the time scale were used to
estimate hazard ratios (HRs) of incident diabetes. Partic-
ipants were censored at their date of death or emigra-
tion. PRAL score was analysed as categorised into
quintiles, with the lowest category as the reference
group. Two multivariate models were used: model 1 was
adjusted for age (as time scale), smoking status (never-
smoker/ex-smoker/current smoker), physical activity
(metabolic equivalent of task (MET)) [21] and total fat,
carbohydrate and energy intake, and model 2 was fur-
ther adjusted for BMI. We tested the assumption of pro-
portional hazards by visual inspection. Due to an uneven
distribution of men and women across the quintiles and
to address the previous diverging findings on men and
women we conducted the analyses in combined datasets
and stratified by sex.
In Inter99 logistic regression models were used to as-
sess the association between PRAL score and IFG, IGT,
and diabetes. Additionally, in Inter99 linear regression
models were used to test whether PRAL score (as a con-
tinuous variable) was associated with diabetes-related
intermediary traits in non-diabetic individuals only (n =
5631). Two multivariate models were used: model 1 was
adjusted for age, sex, total fat, carbohydrate and energy
intake, smoking status (never-smoker/ex-smoker/current
smoker) and level of physical activity (0–2 h/week, 2–
4 h/week, 4–7 h/week, 7–12 h/week) [22] and model 2
was further adjusted for BMI. To test whether the as-
sumptions for linear regression analysis were fulfilled, all
variables were inspected with regards to linearity as well
as homogeneity of variance and normality of the resid-
uals. Natural logarithmic transformation was used to ap-
proximate a normal distribution when needed. Test of
effect modification was performed by introducing the
interaction term in the linear models.
Results
Baseline characteristics of included participants in the
two cohorts are shown in Table 1 as stratified by quin-
tiles of PRAL score. Individuals with a higher PRAL
score had a higher intake of total and saturated fat,
lower intake of fruits and vegetables and higher daily en-
ergy intake (see Table 1). In the subsequent analyses, we
adjusted for these differences.
Outcome from analyses of the DCH cohort
During a mean follow-up period of 15 years 7201 inci-
dent cases of diabetes occurred in the total study popu-
lation. Multifactor adjusted HRs (model 1) of diabetes
were 1.06 (95% CI 0.98; 1.15) (p = 0.12), 1.10 (95% CI
1.02; 1.19) (p = 0.02), 1.13 (95% CI 1.04; 1.22) (p = 0.003)
and 1.24 (95% CI 1.14; 1.35) (p = 7 × 10− 7), respectively,
for the second, third, fourth and fifth quintile versus the
first quintile of PRAL score (ptrend = 6 × 10
− 7) (Fig. 1).
Further adjustment for BMI attenuated the HRs as HR
for the 5th vs. the 1st quintile was 1.10 (95% CI 1.01;
1.20) (p = 0.03) (Fig. 1, model 2), but the same trend was
observed across the quintiles (ptrend = 0.04). In the sex
stratified analyses a similar association was observed for
both men and women (Fig. 2). However, when BMI
was included in the model the association with
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Table 1 Baseline characteristics of study participants in the Inter99 study and in the DCH cohort by quintiles of PRAL score
Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 Total
Inter99 (n = 5631)
Participants, n 1127 1126 1126 1126 1126 5631
PRAL range, mEq/d −92; − 13 −13; − 3 −3; 4 4; 12 12; 90 −92; 90
Men, n (%) 469 (42) 530 (47) 487 (43) 581 (52) 722 (64) 2789 (50)
Age, years 50 (41; 55) 50 (40; 55) 45 (40; 50) 45 (40; 50) 45 (40; 50) 45 (40; 50)
BMI, kg/m2 26.2 ± 4.5 26.1 ± 4.4 26.1 ± 4.6 26.1 ± 4.3 26.3 ± 4.6 26.2 ± 4.5
Physical activity, min/week (%)
0–112 117 (10) 136 (12) 133 (12) 157 (14) 155 (14) 698 (12)
142.5–225 246 (22) 248 (22) 261 (23) 256 (23) 256 (23) 1267 (23)
255–420 601 (53) 586 (52) 609 (54) 573 (51) 571 (51) 2940 (52)
450–720 163 (14) 156 (14) 123 (11) 140 (12) 144 (13) 726 (13)
Smoking, n (%)
Current 539 (48) 444 (39) 420 (37) 390 (35) 396 (35) 2189 (39)
Former 283 (25) 304 (27) 292 (26) 287 (25) 267 (24) 1433 (25)
Never 305 (27) 378 (34) 414 (37) 449 (40) 463 (41) 2009 (36)
Energy intake, KJ/d 9286 ± 3082 9043 ± 2878 9049 ± 2861 9605 ± 2866 11,039 ± 3163 9604 ± 3064
Protein, g/d 76 ± 23 77 ± 23 79 ± 23 85 ± 23 103 ± 28 84 ± 26
Carbohydrates, g/d 293 ± 114 268 ± 96 263 ± 93 274 ± 92 302 ± 98 280 ± 100
Dietary fiber, g/d 23 ± 11 21 ± 8 20 ± 8 21 ± 8 23 ± 9 22 ± 9
Fat intake total, g/d 67 (51; 88) 72 (56; 94) 76 (59; 98) 84 (66; 107) 103 (79; 132) 80 (60; 105)
Saturated fat, g/d 25 (18; 35) 28 (21; 38) 29 (22; 39) 33 (25; 43) 40 (30; 53) 31 (22; 42)
Diet, Cancer and Health (n = 54,651)
Participants, n 10,931 10,930 10,930 10,930 10,930 54,651
PRAL range, mEq/d − 117; −10 −10; −3 −3; 4 4; 12 12; 89 −117; 89
Men, n (%) 3564 (33) 4215 (39) 4838 (44) 5789 (53) 7402 (68) 25,808 (47)
Age, years 55 (52; 60) 56 (52; 60) 56 (52; 60) 56 (52; 60) 55 (52; 60) 56 (52; 60)
BMI, kg/m2 25.6 ± 3.9 25.8 ± 4.0 26.0 ± 3.9 26.1 ± 4.0 26.4 ± 4.1 26.0 ± 4.0
Physical activity, MET-h/week 59 (39; 88) 56 (37; 84) 56 (36; 82) 56 (37; 83) 57 (37; 87) 57 (37; 85)
Smoking, n (%)
Current 4551 (42) 4203 (38) 3723 (34) 3615 (33) 3605 (33) 15,713 (29)
Former 2963 (27) 2948 (27) 3125 (29) 3287 (30) 3390 (31) 19,697 (36)
Never 3417 (31) 3779 (35) 4082 (37) 4028 (37) 3935 (36) 19,241 (35)
Energy intake, KJ/d 9013 ± 2463 9026 ± 2405 9374 ± 2432 9948 ± 2467 11,384 ± 2745 9749 ± 2657
Protein, g/d 82 ± 23 86 ± 23 91 ± 23 99 ± 24 119 ± 29 95 ± 28
Carbohydrates, g/d 254 ± 78 240 ± 71 243 ± 70 252 ± 70 276 ± 75 253 ± 74
Dietary fiber, g/d 22 ± 8 20 ± 7 20 ± 7 20 ± 6 22 ± 7 21 ± 7
Fat intake total, g/d 67 (53; 83) 73 (58; 89) 78 (64; 96) 86 (70; 105) 104 (86; 126) 81 (64; 101)
Saturated fat, g/d 25 (19; 32) 28 (22; 35) 30 (24; 37) 33 (27; 41) 40 (33; 49) 31 (24; 39)
Food intake, g/d
Red meat 63 (46; 84) 70 (52; 93) 77 (57; 101) 85 (63; 112) 105 (75; 141) 78 (56; 107)
Fish 32 (21; 46) 35 (23; 49) 37 (25; 52) 41 (28; 57) 49 (33; 70) 38 (25; 55)
Dairy products 263 (121; 515) 278 (138; 536) 289 (152; 547) 307 (172; 576) 344 (206; 617) 295 (156; 560)
Vegetables 180 (113; 272) 158 (100; 223) 151 (99; 213) 148 (97; 207) 155 (104; 213) 157 (102; 224)
Fruit 202 (107; 350) 154 (81; 254) 141 (74; 224) 131 (68; 204) 117 (61; 189) 145 (75; 240)
Data are mean ± standard deviation or median (inter quartile range) unless otherwise specified. Descriptive data on the Inter99 cohort are on non-diabetic
individuals only. MET Metabolic Equivalent of Task, PRAL Potential Renal Acid Load
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incident diabetes disappeared for men, but remained
significant for women (ptrend = 0.02).
Outcome from analyses of the Inter99 study
The multifactor-adjusted odds ratio (OR) for a one
standard deviation higher PRAL score was 1.11 (95% CI
1.01; 1.22) (p = 0.03) for IGT (Fig. 3). The OR dimin-
ished with further adjustment for BMI (p = 0.11). No sig-
nificant association was observed between PRAL score
and T2D (Fig. 3) and PRAL score and IFG. However,
when adjusting for BMI we found an association be-
tween lowered PRAL score and IFG with an OR of 0.89
(95% CI 0.80; 0.99) (p = 0.03).
A higher PRAL score was associated with lower
OGTT-based measures of insulin resistance (model 1) as
expressed by decreased BIGTT-Si (p = 4 × 10− 7) and
ISIMatsuda (p = 2 × 10
− 5) as well as increased HOMA-IR
(p = 0.001) (Table 2). Accordingly, a higher PRAL score
was associated with higher serum insulin levels at fasting
and 120 min during the OGTT (p = 2 × 10− 4 and p = 8 ×
10− 16, respectively), and with higher plasma glucose
levels at 120 min (p = 4 × 10− 10) (Table 2). No associa-
tions were observed between PRAL score and corrected
insulin response (p = 0.2) or insulinogenic index (p =
0.3), both of which are indices of beta cell function. In
addition, a higher PRAL score was associated with a
lower OGTT-based disposition index (p = 0.004). All
findings remained significant after further adjustment
for BMI (model 2) and with similar effect sizes.
When testing for effect modification we introduced
the interaction term PRAL×sex in the linear regression
models, but the interaction terms were not significant
(data not shown). However; to address diverging
previous findings in men and women we further strati-
fied by sex. We found that a higher PRAL score was as-
sociated with indices of insulin sensitivity in both
women and men (Table 3), but the association with in-
creased HOMA-IR with increased PRAL score was only
apparent in women. Furthermore, an association be-
tween higher PRAL score and lower HbA1c was seen in
men, but only after adjustment for BMI. No associations
were found between PRAL score and indices of beta cell
function in the sex stratified analyses, but a higher PRAL
score was associated with lower disposition index in
women (Table 3).
Sensitivity analysis
In the Inter99 cohort we further did a sensitivity analysis
where we adjusted for family history of diabetes,
hypertension and dietary patterns (see Additional file 1:
TableS1). This information was not available to us in the
DCH cohort, and so the sensitivity analysis was only
conducted in the Inter99 cohort. The sensitivity analysis
showed comparable associations as demonstrated in the
primary analyses except the associations between PRAL
score and HbA1c and disposition index. In the sensitiv-
ity analysis the two latter associations became
non-significant (see Additional file 1: TableS1).
Discussion
In the DCH cohort of more than 54,000 individuals with
~ 7200 incident cases of diabetes after 15 years of
follow-up, we demonstrated a positive relationship be-
tween PRAL score and development of incident dia-
betes, substantiating previous findings [6–10]. Moreover,
in baseline data from the Inter99 study of 5631 non-
Fig. 1 Hazard ratio (HR) of incident diabetes according to PRAL score quintiles in the full DCH cohort. Age is used as the time scale in the cox
model. Model 1 is adjusted for fat, energy and carbohydrate intake, smoking and physical activity, while model 2 is adjusted for BMI, fat, energy
and carbohydrate intake, smoking and physical activity. Squares indicate HR for model 1, and circles indicate HR for model 2. The p-value shown
indicates significance of a trend test
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Fig. 3 PRAL score and glucose tolerance status among participants of the Inter99 study. Odds ratios (OR) of impaired fasting glucose (IFG), impaired
glucose tolerance (IGT) and type 2 diabetes (T2D) according to PRAL score as shown for one standard deviation of PRAL score in the total population
(16.36 mEq/day). Model 1 is adjusted for age, sex, smoking, physical activity and fat, energy and carbohydrate intake, while model 2 is adjusted for age,
sex, BMI, smoking, physical activity and fat, energy and carbohydrate intake. NGT = Normal Glucose Tolerance. Participants having combined IFG and
IGT were classified as IGT. Squares indicate OR for model 1, and circles indicate OR for model 2
Fig. 2 Hazard ratio (HR) of incident diabetes according to PRAL score quintiles in the DCH cohort stratified by sex. Age is used as the time scale
in the cox model. Model 1 is adjusted for fat, energy and carbohydrate intake, smoking and physical activity, while model 2 is adjusted for BMI,
fat, energy and carbohydrate intake, smoking and physical activity. Squares indicate HR for model 1, and circles indicate HR for model 2. The
p-value shown indicates significance of a trend test
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diabetic individuals with OGTT-derived data, we found
that a higher PRAL score was associated with reduced
insulin sensitivity, but not with changes in proxies of
beta cell function. In addition, higher PRAL score
was associated with a lower OGTT-based disposition
index. We did not observe any major diverging re-
sults between the sexes, and so we cannot confirm
that any specific differences exist in regards to PRAL
score and sex. When adjusting for BMI in the DCH
cohort, only the increased HR between the first and
the fifth quintiles remained significant. Furthermore,
when adjusting for BMI, the significant trend seen in
males disappeared, but remained significant in
women. In the Inter99 cohort, adjustment for BMI
had no effect on the analyses. Since the individuals
with a higher PRAL score generally had a higher
overall energy intake, the increased BMI may be part
of the explanation for the increased incidence of dia-
betes. However, since the associations persist even
after adjustment for BMI, it shows that there is in-
deed an association between PRAL score and incident
diabetes as well as diabetes intermediary traits which
is independent of BMI.
Despite a lack of association with indices of beta-cell
function in the Inter99 study, we did find an association
with lower disposition index as an indication of a de-
creased beta cell secretion of insulin at the concomitant
level of insulin resistance. Hence, we cannot completely
discard an association between PRAL score and beta-cell
function. Higher PRAL score is consistent with a gener-
ally unhealthy diet, which is reflected in our finding that
individuals with a higher PRAL score also had a higher
intake of total and saturated fat, lower intake of fruits
and vegetables and higher daily energy intake. We have
accounted for these confounders by adjusting for dietary
fat, carbohydrate and total energy intake in our analyses.
The different nutrients, especially protein, embedded
in the calculation of the PRAL score may come from
various sources. Since the amino acid composition of
plant proteins is different from the composition of
animal proteins, it is possible that ingestion of plant
proteins will have a different effect on the tissue acid-
ity than animal proteins. Indeed, a previous study
showed an association between incident T2D and ani-
mal protein intake, but not with plant protein intake
[23]. One could therefore speculate that a type of
Table 2 Associations between PRAL score and diabetes-related intermediary traits in the baseline part of Inter99 study as well as
means and medians for the individual quintiles
Variable Quintile 1 Quintile 2 Quintile 3 Quintile 4 Quintile 5 BetaModel 1 (95%CI) PModel 1 PModel 2
PRAL range (mEq/d) −92; −13 −13; −3 −3; 4 4; 12 12; 90
HBA1C (%)a 5.9 ± 0.5 5.8 ± 0.5 5.8 ± 0.5 5.8 ± 0.6 5.8 ± 0.5 −0.0009 (−0.002; −5 × 10−5) 0.04 0.01
Plasma glucose (mmol/l)
Fastinga 5.6 ± 0.8 5.5 ± 0.8 5.5 ± 0.6 5.6 ± 0.9 5.5 ± 0.9 − 0.0003 (− 0.002; 0.001) 0.7 0.2
30 mina 8.7 ± 2.0 8.7 ± 1.9 8.6 ± 1.9 8.6 ± 1.8 8.7 ± 1.8 − 0.0009 (− 0.004; 0.002) 0.6 0.2
120 min 5.7 (4.8; 6.9) 5.9 (4.9; 6.9) 5.9 (4.9; 6.9) 6.0 (5.0; 7.0) 5.9 (5.0; 7.0) 0.2 (0.1; 0.2) 4 × 10−10 1 × 10−8
Serum insulin (pmol/l)
Fasting 32 (22; 47) 33 (23; 50) 36 (24; 52) 35 (25; 53) 36 (25; 53) 0.2 (0.09; 0.3) 2 × 10−4 0.008
30 min 239 (171; 334) 234 (165; 346) 243 (181; 349) 257 (178; 376) 257 (183; 368) 0.07 (− 0.03; 0.2) 0.2 0.8
120 min 145 (86; 230) 151 (96; 246) 164 (103; 253) 162 (103; 273) 162 (95; 273) 0.6 (0.4; 0.7) 8 × 10−16 6 × 10−14
Measures of beta cell function
Insulinogenic index 24.2 (16.5; 35.4) 23.4 (15.9; 34.7) 24.7 (17.2; 36.3) 25.8 (17.2; 38.8) 25.4 (17.2; 37.5) 0.06 (−0.06; 0.2) 0.3 0.8
Corrected insulin
response
638 (392; 1051) 602 (392; 1033) 689 (413; 1107) 691 (410; 1146) 679 (413; 1094) 0.09 (−0.04; 0.2) 0.2 0.3
Measures of insulin sensitivity
HOMA-IR 1.3 (0.89; 2.0) 1.3 (0.89; 2.1) 1.4 (0.94; 2.2) 1.4 (0.98; 2.2) 1.4 (0.97; 2.2) 0.2 (0.07; 0.3) 0.001 0.04
ISIMatsuda 8.4 (5.6; 11.7) 8.1 (5.3; 11.9) 7.8 (5.1; 11.1) 7.5 (5.1; 10.9) 7.6 (4.9; 10.8) −0.2 (− 0.3; − 0.1) 2 × 10
−5 0.001
BIGTT-Sia 9.7 ± 4.1 9.4 ± 4.1 9.3 ± 4.0 9.0 ± 4.0 8.8 ± 4.0 −0.02 (− 0.03; − 0.01) 4 × 10−7 4 × 10−7
Disposition Index 304 (211; 447) 291 (200; 410) 298 (203; 419) 297 (205; 412) 306 (206; 415) −0.2 (− 0.3; − 0.05) 0.004 0.02
Data are from the Inter99 cohort (n = 5631) and are presented as mean ± standard deviation or median (inter quartile range) for each quintile of PRAL
score as a description of the cohort. Effect sizes (95% confidence interval) are calculated using linear models with PRAL score as a continuous variable
and are given as percentage increase for a one unit increase in PRAL score except for variables that have not been transformed by the natural logarithm
in which case it is given as an increase per unit. The linear regression model 1 was adjusted for age, sex, smoking, physical activity and fat, energy and
carbohydrate intake. The linear regression model 2 was further adjusted for BMI. BIGTT-Si was not adjusted for sex as this variable is included
in the calculation of BIGTT-Si. Calculations of measures of beta cell function and insulin sensitivity were carried out as described in methods.
Variables were transformed by the natural logarithm unless otherwise indicated by (a). Quintile values are raw data and are for descriptive
purposes only
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measure where proteins were reported as of their ori-
gin or corresponding amino acids would provide use-
ful information about the underlying theories of
dietary acidity load and diabetes.
The amount of dietary fiber ingested are surprisingly
similar across the quintiles. However, the food items
from where the dietary fiber is obtained may vary con-
siderably and may therefore have different impacts on
the PRAL score. For instance, dietary fibers originating
from vegetables and fruits will have an alkalizing effect
and thus decrease the PRAL score, whereas dietary fiber
originating from whole grain may have a different effect
on the PRAL score [1]. As appears from the baseline
table (Table 1) of the DCH cohort, the dietary fiber
ingested in the lower quintiles must come from fruits
and vegetables, whereas the dietary fiber in the higher
quintiles originate from other food items, although we
cannot say for certain which ones. Additionally, it is
noteworthy that the quintiles with the highest PRAL
scores are also the ones with the highest number of
current smokers. This is the case in both the DCH co-
hort and the Inter99 cohort. It cannot be excluded that
smoking status might influence food preferences. Indeed,
a study by Endoh et al. shows, that the dietary patterns
in Japanese men and women differ between smokers and
non-smokers [24].
An intervention study conducted in American adults
showed that individuals would be able to lower their
PRAL score by 13 units when following a vegan diet for
two to three days a week, while a reduction of almost
30 units was seen in individuals following the vegan diet
every day in a week [25]. If we examine our data from
the DCH cohort, we find that a reduction of 30 units
would be sufficient to move an individual from Q4 to
Q1. With a reduction of just 12 units an individual
would step down an entire quintile. Despite the modest
increased risk of diabetes between the lowest and the
highest quintile, diabetes is still major burden in soci-
ety today, and even slight reductions in this risk
through a diet change might have considerable impact
on public health.
Our study has limitations. First, in the present epi-
demiological studies, we did not use the hyperinsuline-
mic euglycemic clamp to measure insulin sensitivity, as
this would not be feasible in such large cohorts; still the
surrogate measures applied in the current study,
HOMA-IR, ISIMatsuda and BIGTT-Si, have all been vali-
dated in previous studies and provide physiologically
relevant proxies for insulin sensitivity [26–28]. Addition-
ally, to overcome any uncertainties in the individual sur-
rogate measures, we have used several different proxies
of insulin sensitivity to measure the same outcome.
Second, and most important, in our study of incident
diabetes, information was collected at baseline only.
Consequently, all conclusions based on the DCH cohort
rely on the assumption that the study participants have
not changed their diet or lifestyle substantially over the
following 15 years of follow-up. Third, the diagnosis of
diabetes was based on The Danish National Diabetes
Register which does not clearly distinguish between pa-
tients with type 1 diabetes or T2D [12]. Yet, individuals
in our study were at least 50 years of age at baseline,
and since newly diagnosed type 1 diabetes is quite rare
in Denmark above this age we do not expect this lack of
diagnostic accuracy to bias our analytical outcomes. The
PRAL score in our two cohorts ranged from around −
100 to 100 and with a median range of − 20.6 to 18.6 in
the Inter99 cohort and − 16.3 to 18.0 in the DCH cohort,
respectively. These median ranges are roughly the same
as in the two studies by Kiefte-de Jong et al. (− 17.4 to
21.3) and Fagherazzi et al. (− 23.0 to 14.3). However, the
PRAL score range in the study by Xu et al. was from −
40 to 323. For histograms of the PRAL scores in the two
cohorts, please see Additional file 1: FigureS3 and
FigureS4. We believe that these between study differ-
ences may be related to differences in dietary patterns
and the demographics of the study populations. Further-
more, the variations in PRAL score may occur due to
differences in how the questionnaires and food compos-
ition tables are structured between studies.
Conclusions
We confirm the association of a high acidity load with
incident T2D and suggest that the risk of T2D might be
mediated partially through a decrease in insulin sensitiv-
ity. Although the present study and previous reports
suggest a link between dietary acidity load and incident
diabetes among middle-aged people, carefully designed
and conducted dietary interventions are needed to eluci-
date whether a causal link exists between the two and
which mechanisms might be involved.
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